Loading...
Market cap
$Loading...
Sector
Loading...
Dividend Yield
Loading...
52-week range
Loading...
Loading...
Description
Loading...
| Returns | 1M | 6M | 1Y | 5Y | 10Y |
|---|---|---|---|---|---|
| $XBI | N/A | N/A | N/A | N/A | N/A |
| S&P500 | N/A | N/A | N/A | N/A | N/A |
| Valuation | P/E Ratio (TTM) | P/S Ratio (TTM) |
|---|---|---|
| SPDR S&P Biotech ETF | Loading... | Loading... |
| Sector Name | Loading... | N/A |
Sector Diversification
Holdings
| Ticker | Name | % of Total |
|---|---|---|
| GVMXX | State Street Navigator Securities Lending Portfolio II | 5.55% |
| APGE | Apogee Therapeutics Inc | 1.41% |
| MRNA | Moderna Inc | 1.33% |
| TWST | Twist Bioscience Corp | 1.33% |
| ORKA | Oruka Therapeutics Inc | 1.30% |
| KYMR | Kymera Therapeutics Inc | 1.28% |
| VKTX | Viking Therapeutics Inc | 1.23% |
| PRAX | Praxis Precision Medicines Inc | 1.22% |
| ERAS | Erasca Inc | 1.20% |
| RVMD | Revolution Medicines Inc | 1.14% |
| RYTM | Rhythm Pharmaceuticals Inc | 1.13% |
| CGON | CG oncology Inc | 1.13% |
| SLS | SELLAS Life Sciences Group Inc | 1.12% |
| PCVX | Vaxcyte Inc | 1.12% |
| DNTH | Dianthus Therapeutics Inc | 1.12% |
| CYTK | Cytokinetics Inc | 1.11% |
| NTRA | Natera Inc | 1.10% |
| SRRK | Scholar Rock Holding Corp | 1.09% |
| ROIV | Roivant Sciences Ltd | 1.09% |
| MIRM | Mirum Pharmaceuticals Inc | 1.09% |
| COGT | Cogent Biosciences Inc | 1.08% |
| RARE | Ultragenyx Pharmaceutical Inc | 1.08% |
| TVTX | Travere Therapeutics Inc | 1.06% |
| ALKS | Alkermes PLC | 1.05% |
| KRYS | Krystal Biotech Inc | 1.04% |
| CELC | Celcuity Inc | 1.04% |
| RLAY | Relay Therapeutics Inc | 1.04% |
| SYRE | Spyre Therapeutics Inc | 1.04% |
| TGTX | TG Therapeutics Inc | 1.03% |
| BEAM | Beam Therapeutics Inc | 1.02% |
| INSM | Insmed Inc | 1.02% |
| PTGX | Protagonist Therapeutics Inc | 1.02% |
| ARWR | Arrowhead Pharmaceuticals Inc | 1.01% |
| VERA | Vera Therapeutics Inc | 1.00% |
| VRTX | Vertex Pharmaceuticals Inc | 1.00% |
| MDGL | Madrigal Pharmaceuticals Inc | 1.00% |
| ABBV | AbbVie Inc | 0.98% |
| BIIB | Biogen Inc | 0.97% |
| PTCT | PTC Therapeutics Inc | 0.97% |
| HALO | Halozyme Therapeutics Inc | 0.97% |
| QURE | uniQure NV | 0.97% |
| BBIO | Bridgebio Pharma Inc | 0.97% |
| CRSP | CRISPR Therapeutics AG | 0.97% |
| IBRX | ImmunityBio Inc | 0.96% |
| SMMT | Summit Therapeutics Inc | 0.96% |
| IONS | Ionis Pharmaceuticals Inc | 0.95% |
| INCY | Incyte Corp | 0.94% |
| AMGN | Amgen Inc | 0.94% |
| NBIX | Neurocrine Biosciences Inc | 0.92% |
| GILD | Gilead Sciences Inc | 0.91% |
| REGN | Regeneron Pharmaceuticals Inc | 0.91% |
| EXEL | Exelixis Inc | 0.91% |
| ALNY | Alnylam Pharmaceuticals Inc | 0.91% |
| BMRN | BioMarin Pharmaceutical Inc | 0.89% |
| ACAD | ACADIA Pharmaceuticals Inc | 0.89% |
| NUVL | Nuvalent Inc | 0.88% |
| IMVT | Immunovant Inc | 0.87% |
| UTHR | United Therapeutics Corp | 0.87% |
| NTLA | Intellia Therapeutics Inc | 0.86% |
| GRAL | GRAIL Inc | 0.86% |
| BCRX | BioCryst Pharmaceuticals Inc | 0.84% |
| CPRX | Catalyst Pharmaceuticals Inc | 0.83% |
| DYN | Dyne Therapeutics Inc | 0.81% |
| TNGX | Tango Therapeutics Inc | 0.80% |
| DNLI | Denali Therapeutics Inc | 0.79% |
| VCYT | Veracyte Inc | 0.77% |
| IDYA | Ideaya Biosciences Inc | 0.76% |
| RXRX | Recursion Pharmaceuticals Inc | 0.71% |
| SRPT | Sarepta Therapeutics Inc | 0.71% |
| RCUS | Arcus Biosciences Inc | 0.70% |
| SNDX | Syndax Pharmaceuticals Inc | 0.68% |
| ARQT | Arcutis Biotherapeutics Inc | 0.67% |
| MLYS | Mineralys Therapeutics Inc | 0.67% |
| CLDX | Celldex Therapeutics Inc | 0.66% |
| AGIO | Agios Pharmaceuticals Inc | 0.65% |
| VRDN | Viridian Therapeutics Inc | 0.63% |
| NVAX | Novavax Inc | 0.62% |
| IRON | Disc Medicine Inc | 0.62% |
| ADMA | ADMA Biologics Inc | 0.57% |
| IMNM | Immunome Inc | 0.56% |
| PVLA | Palvella Therapeutics Inc | 0.55% |
| IOVA | Iovance Biotherapeutics Inc | 0.53% |
| ABSI | Absci Corp | 0.53% |
| NRIX | Nurix Therapeutics Inc | 0.52% |
| KOD | Kodiak Sciences Inc | 0.51% |
| BHVN | Biohaven Ltd | 0.50% |
| VCEL | Vericel Corp | 0.47% |
| ANAB | AnaptysBio Inc | 0.47% |
| CAPR | Capricor Therapeutics Inc | 0.46% |
| STOK | Stoke Therapeutics Inc | 0.45% |
| GLUE | Monte Rosa Therapeutics Inc | 0.45% |
| VIR | Vir Biotechnology Inc | 0.44% |
| PURR | Hyperliquid Strategies Inc | 0.44% |
| TYRA | Tyra Biosciences Inc | 0.39% |
| CRVS | Corvus Pharmaceuticals Inc | 0.39% |
| CGEM | Cullinan Therapeutics Inc | 0.38% |
| PGEN | Precigen Inc | 0.36% |
| INBX | Inhibrx Biosciences Inc | 0.33% |
| TSHA | Taysha Gene Therapies Inc | 0.33% |
| ARDX | Ardelyx Inc | 0.33% |
| AVTX | Avalo Therapeutics Inc | 0.33% |
| MNKD | MannKind Corp | 0.32% |
| ANNX | Annexon Inc | 0.31% |
| ORIC | ORIC Pharmaceuticals Inc | 0.31% |
| ZBIO | Zenas Biopharma Inc | 0.30% |
| JBIO | Jade Biosciences Inc | 0.30% |
| KURA | Kura Oncology Inc | 0.30% |
| OLMA | Olema Pharmaceuticals Inc | 0.30% |
| CDNA | CareDx Inc | 0.29% |
| BCAX | Bicara Therapeutics Inc | 0.29% |
| VOR | Vor BioPharma Inc | 0.28% |
| XNCR | Xencor Inc | 0.27% |
| AVBP | ArriVent Biopharma Inc | 0.27% |
| REPL | Replimune Group Inc | 0.27% |
| CTMX | CytomX Therapeutics Inc | 0.26% |
| JANX | Janux Therapeutics Inc | 0.26% |
| SION | Sionna Therapeutics Inc | 0.25% |
| GERN | Geron Corp | 0.25% |
| SLDB | Solid Biosciences Inc | 0.23% |
| RIGL | Rigel Pharmaceuticals Inc | 0.22% |
| ALLO | Allogene Therapeutics Inc | 0.22% |
| SANA | Sana Biotechnology Inc | 0.22% |
| ALT | Altimmune Inc | 0.22% |
| RGNX | REGENXBIO Inc | 0.21% |
| IRWD | Ironwood Pharmaceuticals Inc | 0.20% |
| IMMX | Immix Biopharma Inc | 0.19% |
| OCGN | Ocugen Inc | 0.19% |
| FDMT | 4D Molecular Therapeutics Inc | 0.19% |
| CADL | Candel Therapeutics Inc | 0.18% |
| SVRA | Savara Inc | 0.17% |
| PRME | Prime Medicine Inc | 0.17% |
| TRAX | First Tracks Biotherapeutics Inc | 0.16% |
| GLTO | Damora Therapeutics Inc | 0.16% |
| SPRY | ARS Pharmaceuticals Inc | 0.16% |
| MPLT | MapLight Therapeutics Inc | 0.16% |
| ABUS | Arbutus Biopharma Corp | 0.16% |
| MYGN | Myriad Genetics Inc | 0.15% |
| CABA | Cabaletta Bio Inc | 0.14% |
| CMPX | Compass Therapeutics Inc | 0.13% |
| EBS | Emergent BioSolutions Inc | 0.13% |
| PRTA | Prothena Corp PLC | 0.13% |
| VNDA | Vanda Pharmaceuticals Inc | 0.12% |
| CATX | Perspective Therapeutics Inc | 0.12% |
| OVID | Ovid therapeutics Inc | 0.12% |
| VSTM | Verastem Inc | 0.11% |
| MDXG | MiMedx Group Inc | 0.10% |
| LXEO | Lexeo Therapeutics Inc | 0.10% |
| ACHV | Achieve Life Sciences Inc | 0.08% |
| SGMT | Sagimet Biosciences Inc | 0.07% |
| CONTRA METSERA INC | 0.07% | |
| BBOT | BridgeBio Oncology Therapeutics Inc | 0.05% |
| GVMXX | State Street Institutional US Government Money Market Fund | 0.04% |
| CONTRA AKERO THERAPEUT | 0.01% | |
| CONTRA INHIBRX INC | 0.01% | |
| CONTRA MIRATI THERAPEU | 0.01% | |
| CONTRA VERVE THERAPEUT | 0.00% | |
| CONTRA BLUEPRINT MEDIC | 0.00% | |
| RNA | Atrium Therapeutics Inc | 0.00% |
| OMNIAB INC | 0.00% | |
| OMNIAB INC | 0.00% |